Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Udvidet
  • Spliceosome mutations are comm...
  • Citér dette
  • Stav dette
  • Email dette
  • Udskriv
  • Eksportér post
    • Eksportér til RefWorks
    • Eksportér til EndNoteWeb
    • Eksportér til EndNote
  • Permanent link
Spliceosome mutations are common in MPN-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

Spliceosome mutations are common in MPN-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

Bibliografiske detaljer
Main Authors: Chowdhury, O, O'Sullivan, J, Barkas, N, Buck, G, Hamblin, A, Tefferi, A, Al-Ali, H, Barosi, G, Devos, T, Gisslinger, H, Jiang, Q, Kiladjian, J, Mesa, R, Passamonti, F, Ribrag, V, Schiller, G, Vannucchi, A, Zhou, D, McMullin, M, Reiser, D, Zhong, J, Gale, R, Mead, A
Format: Conference item
Udgivet: American Society of Hematology 2018
  • Beholdninger
  • Beskrivelse
  • Lignende værker
  • Medarbejdervisning

Lignende værker

  • Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
    af: Chowdhury, O, et al.
    Udgivet: (2020)
  • Profile of pomalidomide and its potential in the treatment of myelofibrosis
    af: Gowin KL, et al.
    Udgivet: (2015-04-01)
  • The UK Myeloproliferative Neoplasm Registry for Myelofibrosis (UK-MPN-MF registry)
    af: Butt, N, et al.
    Udgivet: (2019)
  • Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach
    af: Alessandra Carobbio, et al.
    Udgivet: (2023-07-01)
  • P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS
    af: J.-J. Kiladjian, et al.
    Udgivet: (2022-06-01)

Søgemuligheder

  • Søg Historie
  • Udvidet søgning

Find flere

  • Gennemse kataloget
  • Gennemse alfabetisk
  • Explore Channels
  • Kursusreservationer
  • Nye værker

Har du brug for hjælp?

  • Søgetips
  • Spørg en bibliotekar
  • FAQ’er